Capacity Building and Advocacy to Achieve Hepatitis C Virus Elimination

Nov 17 2024
Convention Center: Room 23
9:45 AM - 10:45 AM

World Class Speakers

Neil Gupta, MD, MPH
Presenter

Neil Gupta, MD, MPH

Centers for Disease Control and Prevention
Andrew Talal, MD, MPH
Presenter

Andrew Talal, MD, MPH

University at Buffalo
Richard A Manch, MD, FAASLD
Presenter

Richard A Manch, MD, FAASLD

Arizona Liver Health
Pauli Gray, BA
Presenter

Pauli Gray, BA

UCSF DeLIVER Care
Ponni V. Perumalswami, MD, FAASLD
Moderator

Ponni V. Perumalswami, MD, FAASLD

University of Michigan Medical Center
YZ
Moderator

Yousaf Zafar

University of Mississippi Medical Center

Description

Presenters engage stakeholders, including persons with HCV, to discuss key evidence-based, capacity-building models for increasing access to HCV care and treatment along with important advocacy work needed to achieve HCV elimination. This session highlights telemedicine and pharmacy-led models of HCV care and important advocacy work still needed to expand HCV treatment access.  

 

Journey Maps

Presentations

9:45 AM - 9:55 AM
Nov 17 2024
San Diego, CA

Updated Hepatitis C Virus Surveillance Data

Neil Gupta, MD, MPH, Presenter
Hepatitis
9:55 AM - 10:05 AM
Nov 17 2024
San Diego, CA

Evidence-Based Telehealth Models of Hepatitis C Virus Care

Andrew Talal, MD, MPH, Presenter
Hepatitis
10:05 AM - 10:15 AM
Nov 17 2024
San Diego, CA

United States Pharmacist-Based Hepatitis C Virus Elimination Program

Richard A Manch, MD, FAASLD, Presenter
Hepatitis
10:15 AM - 10:25 AM
Nov 17 2024
San Diego, CA

The Need for Addressing Stigma and Other Barriers to Treatment in Primary Care Settings: The Patient Perspective

Pauli Gray, BA, Presenter
Hepatitis

Objectives

  • Describe evidence-based telemedicine models of HCV care and treatment.
  • Define and review pharmacist-based models of HCV care and treatment.
  • Discuss the patient perspective of barriers to HCV treatment in care settings.